PRNewsWire - Health

Ichnos Glenmark Innovation (IGI) erhält FDA-Fast-Track-Zulassung für ISB 2001 zur Behandlung des rezidivierten/refraktären multiplen Myeloms
Kedrion Raises Awareness Around Plasminogen Deficiency
Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
CStone Presents the Latest Preclinical Findings of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) at 2025 AACR